approval · primary record
REMIFENTANIL HYDROCHLORIDE
FDA · NDA · 2025-12-22
| Agency | FDA |
|---|---|
| Submission type | NDA |
| Action date | 2025-12-22 |
| Brand | ULTIVA |
| Sponsor | MYLAN INSTITUTIONAL |
| Route | INJECTION |
Provenance
- Source: openFDA Drugs@FDA
- Fetched at: 2026-10-28T02:35:40.318Z
- Licence class: public-domain
- Verdict: primary-source
- Entity id: FDA:REMIFENTANIL HYDROCHLORIDE:2025-12-22
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.